nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CYP2C19—Thalidomide—leprosy	0.11	0.276	CbGbCtD
Topiramate—CYP2C19—Rifampicin—leprosy	0.106	0.267	CbGbCtD
Topiramate—CYP2C19—Dapsone—leprosy	0.0878	0.221	CbGbCtD
Topiramate—CYP3A4—Rifampicin—leprosy	0.0514	0.129	CbGbCtD
Topiramate—CYP3A4—Dapsone—leprosy	0.0425	0.107	CbGbCtD
Topiramate—GRIK1—peripheral nervous system—leprosy	0.0249	0.101	CbGeAlD
Topiramate—GRIA4—nerve—leprosy	0.0222	0.0901	CbGeAlD
Topiramate—GRIK1—nerve—leprosy	0.0194	0.079	CbGeAlD
Topiramate—GRIA3—nerve—leprosy	0.0181	0.0734	CbGeAlD
Topiramate—CA6—ear—leprosy	0.0153	0.0623	CbGeAlD
Topiramate—Anxiety depression—Thalidomide—leprosy	0.0107	0.0299	CcSEcCtD
Topiramate—GRIA1—nerve—leprosy	0.00964	0.0392	CbGeAlD
Topiramate—GRIA4—eye—leprosy	0.00926	0.0376	CbGeAlD
Topiramate—Mood alteration NOS—Thalidomide—leprosy	0.00871	0.0245	CcSEcCtD
Topiramate—GRIK1—eye—leprosy	0.00812	0.033	CbGeAlD
Topiramate—Status epilepticus—Thalidomide—leprosy	0.00742	0.0208	CcSEcCtD
Topiramate—Swelling face—Dapsone—leprosy	0.00717	0.0201	CcSEcCtD
Topiramate—GRIK2—nerve—leprosy	0.00692	0.0281	CbGeAlD
Topiramate—Thromboembolic event—Thalidomide—leprosy	0.00649	0.0182	CcSEcCtD
Topiramate—GRIK4—testis—leprosy	0.00642	0.0261	CbGeAlD
Topiramate—GRIK4—nervous system—leprosy	0.0063	0.0256	CbGeAlD
Topiramate—Suicide attempt—Dapsone—leprosy	0.00602	0.0169	CcSEcCtD
Topiramate—GRIK3—tendon—leprosy	0.00566	0.023	CbGeAlD
Topiramate—CA1—nerve—leprosy	0.00512	0.0208	CbGeAlD
Topiramate—GRIA4—nervous system—leprosy	0.00498	0.0203	CbGeAlD
Topiramate—GRIK3—testis—leprosy	0.00469	0.0191	CbGeAlD
Topiramate—GRIK5—testis—leprosy	0.00469	0.0191	CbGeAlD
Topiramate—GRIK5—nervous system—leprosy	0.0046	0.0187	CbGeAlD
Topiramate—GRIK3—nervous system—leprosy	0.0046	0.0187	CbGeAlD
Topiramate—Albuminuria—Dapsone—leprosy	0.00458	0.0128	CcSEcCtD
Topiramate—GRIK1—nervous system—leprosy	0.00437	0.0178	CbGeAlD
Topiramate—GRIA3—testis—leprosy	0.00414	0.0168	CbGeAlD
Topiramate—GRIA3—nervous system—leprosy	0.00406	0.0165	CbGeAlD
Topiramate—Dysaesthesia—Thalidomide—leprosy	0.00404	0.0114	CcSEcCtD
Topiramate—GRIA1—eye—leprosy	0.00403	0.0164	CbGeAlD
Topiramate—CA4—nerve—leprosy	0.004	0.0163	CbGeAlD
Topiramate—Lacrimal disorder—Thalidomide—leprosy	0.00391	0.011	CcSEcCtD
Topiramate—Hyporeflexia—Thalidomide—leprosy	0.00385	0.0108	CcSEcCtD
Topiramate—Altered state of consciousness—Thalidomide—leprosy	0.00379	0.0106	CcSEcCtD
Topiramate—Raised liver function tests—Thalidomide—leprosy	0.00379	0.0106	CcSEcCtD
Topiramate—Paraesthesia oral—Thalidomide—leprosy	0.00373	0.0105	CcSEcCtD
Topiramate—Grand mal convulsion—Thalidomide—leprosy	0.00367	0.0103	CcSEcCtD
Topiramate—Sinus bradycardia—Thalidomide—leprosy	0.00357	0.01	CcSEcCtD
Topiramate—White blood cell count decreased—Thalidomide—leprosy	0.00351	0.00987	CcSEcCtD
Topiramate—Lymphopenia—Thalidomide—leprosy	0.00342	0.0096	CcSEcCtD
Topiramate—Sexual dysfunction—Thalidomide—leprosy	0.00312	0.00876	CcSEcCtD
Topiramate—Suicide attempt—Thalidomide—leprosy	0.00308	0.00865	CcSEcCtD
Topiramate—Enlargement abdomen—Thalidomide—leprosy	0.00291	0.00816	CcSEcCtD
Topiramate—GRIK2—eye—leprosy	0.00289	0.0118	CbGeAlD
Topiramate—Toothache—Thalidomide—leprosy	0.00287	0.00807	CcSEcCtD
Topiramate—Deep vein thrombosis—Thalidomide—leprosy	0.00287	0.00807	CcSEcCtD
Topiramate—Embolism—Thalidomide—leprosy	0.00272	0.00765	CcSEcCtD
Topiramate—CA12—eye—leprosy	0.0027	0.011	CbGeAlD
Topiramate—Nail disorder—Thalidomide—leprosy	0.0027	0.00757	CcSEcCtD
Topiramate—Tooth disorder—Thalidomide—leprosy	0.0027	0.00757	CcSEcCtD
Topiramate—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00257	0.0072	CcSEcCtD
Topiramate—Menstrual disorder—Thalidomide—leprosy	0.00257	0.0072	CcSEcCtD
Topiramate—Burning sensation—Thalidomide—leprosy	0.00252	0.00707	CcSEcCtD
Topiramate—Nystagmus—Thalidomide—leprosy	0.00245	0.00687	CcSEcCtD
Topiramate—Metrorrhagia—Thalidomide—leprosy	0.00245	0.00687	CcSEcCtD
Topiramate—Hyperlipidaemia—Thalidomide—leprosy	0.00243	0.00681	CcSEcCtD
Topiramate—Psychotic disorder—Dapsone—leprosy	0.00242	0.0068	CcSEcCtD
Topiramate—CA9—tendon—leprosy	0.00242	0.00984	CbGeAlD
Topiramate—Stupor—Thalidomide—leprosy	0.00234	0.00658	CcSEcCtD
Topiramate—Albuminuria—Thalidomide—leprosy	0.00234	0.00658	CcSEcCtD
Topiramate—Amblyopia—Thalidomide—leprosy	0.00226	0.00636	CcSEcCtD
Topiramate—Hyperaesthesia—Thalidomide—leprosy	0.00223	0.00626	CcSEcCtD
Topiramate—Nasopharyngitis—Dapsone—leprosy	0.00222	0.00623	CcSEcCtD
Topiramate—GRIA1—testis—leprosy	0.00221	0.00899	CbGeAlD
Topiramate—Muscular weakness—Dapsone—leprosy	0.00219	0.00614	CcSEcCtD
Topiramate—GRIA1—nervous system—leprosy	0.00217	0.00882	CbGeAlD
Topiramate—CA1—eye—leprosy	0.00214	0.0087	CbGeAlD
Topiramate—Endocrine disorder—Thalidomide—leprosy	0.00211	0.00592	CcSEcCtD
Topiramate—Pancreatitis—Dapsone—leprosy	0.0021	0.0059	CcSEcCtD
Topiramate—Acne—Thalidomide—leprosy	0.00208	0.00584	CcSEcCtD
Topiramate—Sensory loss—Thalidomide—leprosy	0.00202	0.00567	CcSEcCtD
Topiramate—CA9—testis—leprosy	0.002	0.00815	CbGeAlD
Topiramate—Vasodilation procedure—Thalidomide—leprosy	0.00199	0.00559	CcSEcCtD
Topiramate—Vasodilation—Thalidomide—leprosy	0.00199	0.00559	CcSEcCtD
Topiramate—Amenorrhoea—Thalidomide—leprosy	0.00199	0.00559	CcSEcCtD
Topiramate—Photosensitivity reaction—Dapsone—leprosy	0.00196	0.00549	CcSEcCtD
Topiramate—Musculoskeletal stiffness—Thalidomide—leprosy	0.00195	0.00547	CcSEcCtD
Topiramate—Viral infection—Thalidomide—leprosy	0.00194	0.00544	CcSEcCtD
Topiramate—Skin discolouration—Thalidomide—leprosy	0.00194	0.00544	CcSEcCtD
Topiramate—Arthropathy—Thalidomide—leprosy	0.00192	0.0054	CcSEcCtD
Topiramate—Hypocalcaemia—Thalidomide—leprosy	0.00191	0.00536	CcSEcCtD
Topiramate—Thinking abnormal—Thalidomide—leprosy	0.00191	0.00536	CcSEcCtD
Topiramate—Oliguria—Thalidomide—leprosy	0.0019	0.00533	CcSEcCtD
Topiramate—Drug interaction—Thalidomide—leprosy	0.00188	0.00529	CcSEcCtD
Topiramate—Neuropathy peripheral—Dapsone—leprosy	0.00187	0.00526	CcSEcCtD
Topiramate—Dyskinesia—Thalidomide—leprosy	0.00186	0.00522	CcSEcCtD
Topiramate—Hearing impaired—Thalidomide—leprosy	0.00184	0.00516	CcSEcCtD
Topiramate—Creatinine increased—Thalidomide—leprosy	0.00184	0.00516	CcSEcCtD
Topiramate—Bone pain—Thalidomide—leprosy	0.00183	0.00513	CcSEcCtD
Topiramate—Atrioventricular block—Thalidomide—leprosy	0.0018	0.00506	CcSEcCtD
Topiramate—Sinusitis—Dapsone—leprosy	0.00179	0.00503	CcSEcCtD
Topiramate—Gait disturbance—Thalidomide—leprosy	0.00179	0.00503	CcSEcCtD
Topiramate—Coordination abnormal—Thalidomide—leprosy	0.00178	0.005	CcSEcCtD
Topiramate—GRIA2—testis—leprosy	0.00176	0.00714	CbGeAlD
Topiramate—Pulmonary embolism—Thalidomide—leprosy	0.00175	0.00491	CcSEcCtD
Topiramate—Phosphatase alkaline increased—Thalidomide—leprosy	0.00175	0.00491	CcSEcCtD
Topiramate—GRIA2—nervous system—leprosy	0.00172	0.00701	CbGeAlD
Topiramate—Pharyngitis—Dapsone—leprosy	0.0017	0.00478	CcSEcCtD
Topiramate—Depressed level of consciousness—Thalidomide—leprosy	0.00169	0.00474	CcSEcCtD
Topiramate—Candida infection—Thalidomide—leprosy	0.00167	0.00469	CcSEcCtD
Topiramate—Neuropathy—Thalidomide—leprosy	0.00164	0.00461	CcSEcCtD
Topiramate—Dry eye—Thalidomide—leprosy	0.00162	0.00454	CcSEcCtD
Topiramate—Cramps of lower extremities—Thalidomide—leprosy	0.00161	0.00451	CcSEcCtD
Topiramate—CA5B—tendon—leprosy	0.00161	0.00653	CbGeAlD
Topiramate—Tinnitus—Dapsone—leprosy	0.0016	0.00449	CcSEcCtD
Topiramate—Oesophagitis—Thalidomide—leprosy	0.0016	0.00449	CcSEcCtD
Topiramate—Rash maculo-papular—Thalidomide—leprosy	0.00159	0.00446	CcSEcCtD
Topiramate—SCN1A—nervous system—leprosy	0.00157	0.00639	CbGeAlD
Topiramate—GRIK2—nervous system—leprosy	0.00156	0.00633	CbGeAlD
Topiramate—Hypertonia—Thalidomide—leprosy	0.00153	0.0043	CcSEcCtD
Topiramate—Hyperkinesia—Thalidomide—leprosy	0.00153	0.00428	CcSEcCtD
Topiramate—Mental disability—Thalidomide—leprosy	0.00152	0.00426	CcSEcCtD
Topiramate—Euphoric mood—Thalidomide—leprosy	0.0015	0.00422	CcSEcCtD
Topiramate—Erythema—Dapsone—leprosy	0.00149	0.00419	CcSEcCtD
Topiramate—Lymphadenopathy—Thalidomide—leprosy	0.00149	0.00418	CcSEcCtD
Topiramate—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00146	0.0041	CcSEcCtD
Topiramate—Diabetes mellitus—Thalidomide—leprosy	0.00146	0.0041	CcSEcCtD
Topiramate—CA12—nervous system—leprosy	0.00145	0.00591	CbGeAlD
Topiramate—Gastroenteritis—Thalidomide—leprosy	0.00143	0.00402	CcSEcCtD
Topiramate—Vascular purpura—Thalidomide—leprosy	0.00142	0.00398	CcSEcCtD
Topiramate—Deafness—Thalidomide—leprosy	0.00142	0.00398	CcSEcCtD
Topiramate—Eczema—Thalidomide—leprosy	0.00141	0.00397	CcSEcCtD
Topiramate—Vision blurred—Dapsone—leprosy	0.00141	0.00395	CcSEcCtD
Topiramate—Eye pain—Thalidomide—leprosy	0.00141	0.00395	CcSEcCtD
Topiramate—CA2—eye—leprosy	0.00139	0.00564	CbGeAlD
Topiramate—Libido decreased—Thalidomide—leprosy	0.00137	0.00384	CcSEcCtD
Topiramate—Amnesia—Thalidomide—leprosy	0.00135	0.00379	CcSEcCtD
Topiramate—Increased appetite—Thalidomide—leprosy	0.00135	0.00379	CcSEcCtD
Topiramate—Vertigo—Dapsone—leprosy	0.00134	0.00377	CcSEcCtD
Topiramate—Visual disturbance—Thalidomide—leprosy	0.00134	0.00376	CcSEcCtD
Topiramate—CA5B—testis—leprosy	0.00133	0.00541	CbGeAlD
Topiramate—Purpura—Thalidomide—leprosy	0.00132	0.0037	CcSEcCtD
Topiramate—CA5B—nervous system—leprosy	0.0013	0.00531	CbGeAlD
Topiramate—Cough—Dapsone—leprosy	0.0013	0.00366	CcSEcCtD
Topiramate—Hypoglycaemia—Thalidomide—leprosy	0.0013	0.00365	CcSEcCtD
Topiramate—Lethargy—Thalidomide—leprosy	0.0013	0.00364	CcSEcCtD
Topiramate—Hyponatraemia—Thalidomide—leprosy	0.00127	0.00358	CcSEcCtD
Topiramate—Diplopia—Thalidomide—leprosy	0.00127	0.00356	CcSEcCtD
Topiramate—Osteoarthritis—Thalidomide—leprosy	0.00127	0.00356	CcSEcCtD
Topiramate—Pain in extremity—Thalidomide—leprosy	0.00127	0.00356	CcSEcCtD
Topiramate—SCN5A—nervous system—leprosy	0.00126	0.00514	CbGeAlD
Topiramate—Disturbance in sexual arousal—Thalidomide—leprosy	0.00126	0.00354	CcSEcCtD
Topiramate—Affect lability—Thalidomide—leprosy	0.00125	0.00351	CcSEcCtD
Topiramate—Migraine—Thalidomide—leprosy	0.00125	0.00351	CcSEcCtD
Topiramate—GABRB2—testis—leprosy	0.00125	0.00508	CbGeAlD
Topiramate—Psychotic disorder—Thalidomide—leprosy	0.00124	0.00348	CcSEcCtD
Topiramate—GABRB2—nervous system—leprosy	0.00123	0.00498	CbGeAlD
Topiramate—GABRG2—nervous system—leprosy	0.00123	0.00498	CbGeAlD
Topiramate—Face oedema—Thalidomide—leprosy	0.00123	0.00344	CcSEcCtD
Topiramate—CA2—skin of body—leprosy	0.00121	0.00491	CbGeAlD
Topiramate—Mood swings—Thalidomide—leprosy	0.0012	0.00338	CcSEcCtD
Topiramate—Ataxia—Thalidomide—leprosy	0.00119	0.00335	CcSEcCtD
Topiramate—Tachycardia—Dapsone—leprosy	0.00119	0.00334	CcSEcCtD
Topiramate—Blood creatinine increased—Thalidomide—leprosy	0.00119	0.00334	CcSEcCtD
Topiramate—Dehydration—Thalidomide—leprosy	0.00118	0.00331	CcSEcCtD
Topiramate—Liver function test abnormal—Thalidomide—leprosy	0.00117	0.00329	CcSEcCtD
Topiramate—Orthostatic hypotension—Thalidomide—leprosy	0.00116	0.00326	CcSEcCtD
Topiramate—Hypokalaemia—Thalidomide—leprosy	0.00116	0.00324	CcSEcCtD
Topiramate—CA1—nervous system—leprosy	0.00115	0.00468	CbGeAlD
Topiramate—Breast disorder—Thalidomide—leprosy	0.00115	0.00322	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00114	0.00321	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00114	0.00321	CcSEcCtD
Topiramate—Muscular weakness—Thalidomide—leprosy	0.00112	0.00314	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Thalidomide—leprosy	0.00112	0.00314	CcSEcCtD
Topiramate—CA4—tendon—leprosy	0.00111	0.00451	CbGeAlD
Topiramate—Abdominal distension—Thalidomide—leprosy	0.0011	0.0031	CcSEcCtD
Topiramate—Insomnia—Dapsone—leprosy	0.0011	0.0031	CcSEcCtD
Topiramate—Dysphagia—Thalidomide—leprosy	0.0011	0.00308	CcSEcCtD
Topiramate—Eosinophilia—Thalidomide—leprosy	0.00109	0.00305	CcSEcCtD
Topiramate—GABRA1—nervous system—leprosy	0.00108	0.0044	CbGeAlD
Topiramate—Pancreatitis—Thalidomide—leprosy	0.00108	0.00302	CcSEcCtD
Topiramate—Angina pectoris—Thalidomide—leprosy	0.00107	0.003	CcSEcCtD
Topiramate—Bronchitis—Thalidomide—leprosy	0.00106	0.00296	CcSEcCtD
Topiramate—Pancytopenia—Thalidomide—leprosy	0.00104	0.00293	CcSEcCtD
Topiramate—Neutropenia—Thalidomide—leprosy	0.00103	0.00288	CcSEcCtD
Topiramate—Upper respiratory tract infection—Thalidomide—leprosy	0.00102	0.00286	CcSEcCtD
Topiramate—Pollakiuria—Thalidomide—leprosy	0.00101	0.00285	CcSEcCtD
Topiramate—Erectile dysfunction—Thalidomide—leprosy	0.00101	0.00284	CcSEcCtD
Topiramate—Photosensitivity reaction—Thalidomide—leprosy	0.001	0.00281	CcSEcCtD
Topiramate—Weight increased—Thalidomide—leprosy	0.000998	0.0028	CcSEcCtD
Topiramate—Gastrointestinal pain—Dapsone—leprosy	0.000997	0.0028	CcSEcCtD
Topiramate—Weight decreased—Thalidomide—leprosy	0.000993	0.00279	CcSEcCtD
Topiramate—Hyperglycaemia—Thalidomide—leprosy	0.00099	0.00278	CcSEcCtD
Topiramate—Pneumonia—Thalidomide—leprosy	0.000984	0.00276	CcSEcCtD
Topiramate—Infestation NOS—Thalidomide—leprosy	0.000978	0.00275	CcSEcCtD
Topiramate—Infestation—Thalidomide—leprosy	0.000978	0.00275	CcSEcCtD
Topiramate—Depression—Thalidomide—leprosy	0.000975	0.00274	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00097	0.00272	CcSEcCtD
Topiramate—Body temperature increased—Dapsone—leprosy	0.000963	0.00271	CcSEcCtD
Topiramate—Abdominal pain—Dapsone—leprosy	0.000963	0.00271	CcSEcCtD
Topiramate—Renal failure—Thalidomide—leprosy	0.000962	0.0027	CcSEcCtD
Topiramate—Neuropathy peripheral—Thalidomide—leprosy	0.000959	0.00269	CcSEcCtD
Topiramate—Stomatitis—Thalidomide—leprosy	0.000953	0.00268	CcSEcCtD
Topiramate—Conjunctivitis—Thalidomide—leprosy	0.000951	0.00267	CcSEcCtD
Topiramate—Haematuria—Thalidomide—leprosy	0.000933	0.00262	CcSEcCtD
Topiramate—Epistaxis—Thalidomide—leprosy	0.000923	0.00259	CcSEcCtD
Topiramate—CA2—tendon—leprosy	0.000919	0.00374	CbGeAlD
Topiramate—CA4—testis—leprosy	0.000918	0.00373	CbGeAlD
Topiramate—Sinusitis—Thalidomide—leprosy	0.000918	0.00258	CcSEcCtD
Topiramate—Agranulocytosis—Thalidomide—leprosy	0.000913	0.00256	CcSEcCtD
Topiramate—CA4—nervous system—leprosy	0.000901	0.00366	CbGeAlD
Topiramate—Bradycardia—Thalidomide—leprosy	0.000894	0.00251	CcSEcCtD
Topiramate—Rhinitis—Thalidomide—leprosy	0.00088	0.00247	CcSEcCtD
Topiramate—Hepatitis—Thalidomide—leprosy	0.000878	0.00247	CcSEcCtD
Topiramate—Hypoaesthesia—Thalidomide—leprosy	0.000874	0.00245	CcSEcCtD
Topiramate—Pharyngitis—Thalidomide—leprosy	0.000872	0.00245	CcSEcCtD
Topiramate—Urinary tract disorder—Thalidomide—leprosy	0.000867	0.00244	CcSEcCtD
Topiramate—Oedema peripheral—Thalidomide—leprosy	0.000865	0.00243	CcSEcCtD
Topiramate—Urethral disorder—Thalidomide—leprosy	0.000861	0.00242	CcSEcCtD
Topiramate—Visual impairment—Thalidomide—leprosy	0.000846	0.00238	CcSEcCtD
Topiramate—Erythema multiforme—Thalidomide—leprosy	0.00083	0.00233	CcSEcCtD
Topiramate—Eye disorder—Thalidomide—leprosy	0.000821	0.0023	CcSEcCtD
Topiramate—Tinnitus—Thalidomide—leprosy	0.000819	0.0023	CcSEcCtD
Topiramate—Cardiac disorder—Thalidomide—leprosy	0.000815	0.00229	CcSEcCtD
Topiramate—Angiopathy—Thalidomide—leprosy	0.000797	0.00224	CcSEcCtD
Topiramate—Immune system disorder—Thalidomide—leprosy	0.000793	0.00223	CcSEcCtD
Topiramate—Mediastinal disorder—Thalidomide—leprosy	0.000791	0.00222	CcSEcCtD
Topiramate—Chills—Thalidomide—leprosy	0.000788	0.00221	CcSEcCtD
Topiramate—Alopecia—Thalidomide—leprosy	0.000776	0.00218	CcSEcCtD
Topiramate—Vomiting—Dapsone—leprosy	0.000775	0.00218	CcSEcCtD
Topiramate—Mental disorder—Thalidomide—leprosy	0.000769	0.00216	CcSEcCtD
Topiramate—Malnutrition—Thalidomide—leprosy	0.000764	0.00215	CcSEcCtD
Topiramate—Headache—Dapsone—leprosy	0.000763	0.00214	CcSEcCtD
Topiramate—CA2—testis—leprosy	0.000761	0.00309	CbGeAlD
Topiramate—Flatulence—Thalidomide—leprosy	0.000753	0.00212	CcSEcCtD
Topiramate—Tension—Thalidomide—leprosy	0.00075	0.00211	CcSEcCtD
Topiramate—Dysgeusia—Thalidomide—leprosy	0.000749	0.0021	CcSEcCtD
Topiramate—CA2—nervous system—leprosy	0.000747	0.00304	CbGeAlD
Topiramate—Nervousness—Thalidomide—leprosy	0.000742	0.00208	CcSEcCtD
Topiramate—Back pain—Thalidomide—leprosy	0.000739	0.00208	CcSEcCtD
Topiramate—Muscle spasms—Thalidomide—leprosy	0.000735	0.00206	CcSEcCtD
Topiramate—Nausea—Dapsone—leprosy	0.000724	0.00203	CcSEcCtD
Topiramate—Vision blurred—Thalidomide—leprosy	0.00072	0.00202	CcSEcCtD
Topiramate—Tremor—Thalidomide—leprosy	0.000716	0.00201	CcSEcCtD
Topiramate—Ill-defined disorder—Thalidomide—leprosy	0.000709	0.00199	CcSEcCtD
Topiramate—Anaemia—Thalidomide—leprosy	0.000707	0.00198	CcSEcCtD
Topiramate—Agitation—Thalidomide—leprosy	0.000702	0.00197	CcSEcCtD
Topiramate—Malaise—Thalidomide—leprosy	0.000689	0.00194	CcSEcCtD
Topiramate—Vertigo—Thalidomide—leprosy	0.000687	0.00193	CcSEcCtD
Topiramate—Syncope—Thalidomide—leprosy	0.000686	0.00192	CcSEcCtD
Topiramate—Leukopenia—Thalidomide—leprosy	0.000684	0.00192	CcSEcCtD
Topiramate—Palpitations—Thalidomide—leprosy	0.000676	0.0019	CcSEcCtD
Topiramate—Loss of consciousness—Thalidomide—leprosy	0.000672	0.00189	CcSEcCtD
Topiramate—Cough—Thalidomide—leprosy	0.000667	0.00187	CcSEcCtD
Topiramate—Convulsion—Thalidomide—leprosy	0.000662	0.00186	CcSEcCtD
Topiramate—Hypertension—Thalidomide—leprosy	0.00066	0.00185	CcSEcCtD
Topiramate—Chest pain—Thalidomide—leprosy	0.000651	0.00183	CcSEcCtD
Topiramate—Myalgia—Thalidomide—leprosy	0.000651	0.00183	CcSEcCtD
Topiramate—Arthralgia—Thalidomide—leprosy	0.000651	0.00183	CcSEcCtD
Topiramate—Anxiety—Thalidomide—leprosy	0.000649	0.00182	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000646	0.00181	CcSEcCtD
Topiramate—Discomfort—Thalidomide—leprosy	0.000643	0.00181	CcSEcCtD
Topiramate—Dry mouth—Thalidomide—leprosy	0.000636	0.00179	CcSEcCtD
Topiramate—Confusional state—Thalidomide—leprosy	0.000629	0.00177	CcSEcCtD
Topiramate—Oedema—Thalidomide—leprosy	0.000624	0.00175	CcSEcCtD
Topiramate—Infection—Thalidomide—leprosy	0.00062	0.00174	CcSEcCtD
Topiramate—Shock—Thalidomide—leprosy	0.000614	0.00172	CcSEcCtD
Topiramate—Nervous system disorder—Thalidomide—leprosy	0.000612	0.00172	CcSEcCtD
Topiramate—Thrombocytopenia—Thalidomide—leprosy	0.000611	0.00172	CcSEcCtD
Topiramate—Tachycardia—Thalidomide—leprosy	0.000609	0.00171	CcSEcCtD
Topiramate—Skin disorder—Thalidomide—leprosy	0.000606	0.0017	CcSEcCtD
Topiramate—Hyperhidrosis—Thalidomide—leprosy	0.000603	0.00169	CcSEcCtD
Topiramate—Anorexia—Thalidomide—leprosy	0.000595	0.00167	CcSEcCtD
Topiramate—Hypotension—Thalidomide—leprosy	0.000583	0.00164	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Thalidomide—leprosy	0.000568	0.0016	CcSEcCtD
Topiramate—Insomnia—Thalidomide—leprosy	0.000564	0.00158	CcSEcCtD
Topiramate—Paraesthesia—Thalidomide—leprosy	0.00056	0.00157	CcSEcCtD
Topiramate—Dyspnoea—Thalidomide—leprosy	0.000556	0.00156	CcSEcCtD
Topiramate—Somnolence—Thalidomide—leprosy	0.000555	0.00156	CcSEcCtD
Topiramate—Dyspepsia—Thalidomide—leprosy	0.000549	0.00154	CcSEcCtD
Topiramate—Decreased appetite—Thalidomide—leprosy	0.000542	0.00152	CcSEcCtD
Topiramate—Gastrointestinal disorder—Thalidomide—leprosy	0.000539	0.00151	CcSEcCtD
Topiramate—Fatigue—Thalidomide—leprosy	0.000538	0.00151	CcSEcCtD
Topiramate—Pain—Thalidomide—leprosy	0.000533	0.0015	CcSEcCtD
Topiramate—Constipation—Thalidomide—leprosy	0.000533	0.0015	CcSEcCtD
Topiramate—Feeling abnormal—Thalidomide—leprosy	0.000514	0.00144	CcSEcCtD
Topiramate—Gastrointestinal pain—Thalidomide—leprosy	0.00051	0.00143	CcSEcCtD
Topiramate—Urticaria—Thalidomide—leprosy	0.000496	0.00139	CcSEcCtD
Topiramate—Abdominal pain—Thalidomide—leprosy	0.000493	0.00138	CcSEcCtD
Topiramate—Body temperature increased—Thalidomide—leprosy	0.000493	0.00138	CcSEcCtD
Topiramate—CYP3A4—nervous system—leprosy	0.000482	0.00196	CbGeAlD
Topiramate—Hypersensitivity—Thalidomide—leprosy	0.00046	0.00129	CcSEcCtD
Topiramate—Asthenia—Thalidomide—leprosy	0.000448	0.00126	CcSEcCtD
Topiramate—Pruritus—Thalidomide—leprosy	0.000441	0.00124	CcSEcCtD
Topiramate—Diarrhoea—Thalidomide—leprosy	0.000427	0.0012	CcSEcCtD
Topiramate—Dizziness—Thalidomide—leprosy	0.000413	0.00116	CcSEcCtD
Topiramate—Vomiting—Thalidomide—leprosy	0.000397	0.00111	CcSEcCtD
Topiramate—Rash—Thalidomide—leprosy	0.000393	0.0011	CcSEcCtD
Topiramate—Dermatitis—Thalidomide—leprosy	0.000393	0.0011	CcSEcCtD
Topiramate—Headache—Thalidomide—leprosy	0.000391	0.0011	CcSEcCtD
Topiramate—Nausea—Thalidomide—leprosy	0.000371	0.00104	CcSEcCtD
